MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
135 hedge funds and large institutions have $663M invested in Merrimack Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $931M → $663M (-$269M)
54% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 26
Holders
135
Holding in Top 10
1
Calls
$4.05M
Puts
$2.43M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$12.4M | |
| 3 | +$5.32M | |
| 4 |
TA
Teachers Advisors
New York
|
+$3.82M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.7M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$5.84M | |
| 3 | -$4.33M | |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$4.06M |
| 5 |
Millennium Management
New York
|
-$3.21M |